Biocon Runs Free Oral Cancer Screens
In India
Biocon
Ltd, a biopharmaceuticals company headquartered in India, has successfully run
“Free Oral Screening Camps”, a campaign intended to screen people for oral
cancer and create awareness about the disease.
Oncologists
and nurses conducted oral screening across various centers in 23 Indian cities,
namely Bangalore, Mangalore, Hubli, Coimbatore, Kankanady, Hissar, Mohali,
Nashik, Mumbai, Chennai, Hyderabad, Kolkata, Pune, Patna, Kochi, Jaipur,
Indore, Bhopal, Cuttack, Kanpur, Lucknow, Jalandhar and Aurangbad.
Talking
about Biocon’s drive against cancer, Mr. Shukrit Chimote, vice president and
head of branded formulations, India, said, “As India’s leading oncology
company, Biocon has been making a significant impact in the area of cancer care
through its affordable, life-saving therapies.”
“Through
this initiative we hope to educate a large number of Indians on the risk
factors associated with this killer disease and encourage them to get regular
oral screening by qualified doctors, as a means of early cancer detection, that
can lead to better treatment outcomes.”
Oral
cancer accounts for 30 percent of all cancers in India, with about 77,000 new
cases being diagnosed annually. Tobacco use and excessive alcohol consumption
contribute to 90 percent of oral cancers, awareness about the risk factors can
go a long way in helping prevent the disease. Early detection of oral cancer
through screening programs could mean better treatment outcomes and longer
survival. Oral cancer has an overall 52 percent survival rate after five years,
but when detected early the rate increases to above 80 percent.
Developing
countries like India are challenged with a much larger disease burden due to
aging populations and rising incidence of non-communicable diseases (NCDs) like
diabetes, cancer and autoimmune disorders. Among the NCDs, cancer is the second
largest cause of death in India. Biocon has also been addressing the problem of
cancer in the country through its CSR interventions aimed at early detection of
cervical cancer and oral cancer among marginalized communities and their
management in secondary and tertiary stages.
No comments:
Post a Comment